search
Back to results

Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study (FAPPER)

Primary Purpose

Familial Adenomatous Polyposis (FAP)

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Anti-inflammatory Diet
Sponsored by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Familial Adenomatous Polyposis (FAP) focused on measuring FAP, Familial Adenomatous Polyposis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

- FAP patients carrying mutations in APC gene, submitted to prophylactic total colectomy/IRA (with rectum preservation) and that participate to the regular endoscopic surveillance program at IRCCS-INT.

Exclusion Criteria:

  • FAP patients taking NSAIDs and/or Omega 3
  • Patients who carried MUTYH germline mutations or had no APC mutation found.

Sites / Locations

  • Fondazione IRCCS Istituto Nazionale Tumori

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

FAP patients

Arm Description

FAP patients who underwent prophylactic total colectomy

Outcomes

Primary Outcome Measures

Evaluate changes in calprotectin levels
Change from baseline in calprotectin levels at 3 months and 6 months post anti-inflammatory diet consumption.

Secondary Outcome Measures

Evaluate changes in circulatory inflammatory markers
Change from baseline in circulatory inflammatory markers at 3 months and 6 months post anti-inflammatory diet consumption.
Evaluate the effect on polyps growth
Evaluate the effect of the anti-inflammatory diet on polyps growth in the rectal stump (in terms of number of polyps)
Evaluate changes in the number of diarrheal discharges
Change from baseline in the number of diarrheal discharges at 3 months and 6 months post anti-inflammatory diet consumption
Evaluate changes in the immune cell profile
Change from baseline in the immune cell profile at 3 months and 6 months post anti-inflammatory diet consumption
Evaluate changes in stool inflammatory markers
Change from baseline in stool inflammatory markers at 3 months and 6 months post anti-inflammatory diet consumption

Full Information

First Posted
May 4, 2020
Last Updated
September 10, 2020
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
search

1. Study Identification

Unique Protocol Identification Number
NCT04552405
Brief Title
Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study
Acronym
FAPPER
Official Title
Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
September 12, 2017 (Actual)
Primary Completion Date
February 21, 2018 (Actual)
Study Completion Date
February 21, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Preventive anti-inflammatory diet to reduce gastro-intestinal inflammation in FAP patients: a prospective pilot study
Detailed Description
a prospective pilot study

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Familial Adenomatous Polyposis (FAP)
Keywords
FAP, Familial Adenomatous Polyposis

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Actual)

8. Arms, Groups, and Interventions

Arm Title
FAP patients
Arm Type
Other
Arm Description
FAP patients who underwent prophylactic total colectomy
Intervention Type
Dietary Supplement
Intervention Name(s)
Anti-inflammatory Diet
Intervention Description
FAP individuals followed for 3 months a low-inflammatory diet
Primary Outcome Measure Information:
Title
Evaluate changes in calprotectin levels
Description
Change from baseline in calprotectin levels at 3 months and 6 months post anti-inflammatory diet consumption.
Time Frame
baseline, at 3 months and 6 months post anti-inflammatory diet consumption.
Secondary Outcome Measure Information:
Title
Evaluate changes in circulatory inflammatory markers
Description
Change from baseline in circulatory inflammatory markers at 3 months and 6 months post anti-inflammatory diet consumption.
Time Frame
baseline, at 3 months and 6 months post anti-inflammatory diet consumption.
Title
Evaluate the effect on polyps growth
Description
Evaluate the effect of the anti-inflammatory diet on polyps growth in the rectal stump (in terms of number of polyps)
Time Frame
baseline and 6 months post anti-inflammatory diet consumption
Title
Evaluate changes in the number of diarrheal discharges
Description
Change from baseline in the number of diarrheal discharges at 3 months and 6 months post anti-inflammatory diet consumption
Time Frame
baseline, at 3 months and 6 months post anti-inflammatory diet consumption
Title
Evaluate changes in the immune cell profile
Description
Change from baseline in the immune cell profile at 3 months and 6 months post anti-inflammatory diet consumption
Time Frame
baseline, at 3 months and 6 months post anti-inflammatory diet consumption
Title
Evaluate changes in stool inflammatory markers
Description
Change from baseline in stool inflammatory markers at 3 months and 6 months post anti-inflammatory diet consumption
Time Frame
baseline, at 3 months and 6 months post anti-inflammatory diet consumption

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - FAP patients carrying mutations in APC gene, submitted to prophylactic total colectomy/IRA (with rectum preservation) and that participate to the regular endoscopic surveillance program at IRCCS-INT. Exclusion Criteria: FAP patients taking NSAIDs and/or Omega 3 Patients who carried MUTYH germline mutations or had no APC mutation found.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marco Vitellaro, MD
Organizational Affiliation
Fondazione IRCCS ISTITUTO NAZIONALE TUMORI
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fondazione IRCCS Istituto Nazionale Tumori
City
Milano
ZIP/Postal Code
20133
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
It will be discussed later by the staff
Citations:
PubMed Identifier
18194984
Citation
Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Jarvinen H, Mecklin JP, Moller P, Myrhoi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008 May;57(5):704-13. doi: 10.1136/gut.2007.136127. Epub 2008 Jan 14.
Results Reference
background
PubMed Identifier
21530747
Citation
Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011 May;140(6):1807-16. doi: 10.1053/j.gastro.2011.01.057.
Results Reference
background
PubMed Identifier
8385741
Citation
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993 May 6;328(18):1313-6. doi: 10.1056/NEJM199305063281805.
Results Reference
background
PubMed Identifier
27346644
Citation
Dolan KT, Chang EB. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res. 2017 Jan;61(1):10.1002/mnfr.201600129. doi: 10.1002/mnfr.201600129. Epub 2016 Aug 15.
Results Reference
background
PubMed Identifier
22190020
Citation
Neuhouser ML, Schwarz Y, Wang C, Breymeyer K, Coronado G, Wang CY, Noar K, Song X, Lampe JW. A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr. 2012 Feb;142(2):369-74. doi: 10.3945/jn.111.149807. Epub 2011 Dec 21.
Results Reference
background
PubMed Identifier
17158434
Citation
Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr. 2006 Dec;84(6):1489-97. doi: 10.1093/ajcn/84.6.1489.
Results Reference
background
PubMed Identifier
19074209
Citation
Azadbakht L, Esmaillzadeh A. Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women. J Nutr. 2009 Feb;139(2):335-9. doi: 10.3945/jn.108.096297. Epub 2008 Dec 11.
Results Reference
background
PubMed Identifier
18842776
Citation
Esmaillzadeh A, Azadbakht L. Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am J Clin Nutr. 2008 Oct;88(4):913-21. doi: 10.1093/ajcn/88.4.913.
Results Reference
background
PubMed Identifier
17392557
Citation
Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care. 2007 Apr;30(4):967-73. doi: 10.2337/dc06-2126.
Results Reference
background
PubMed Identifier
21653577
Citation
de Oliveira Otto MC, Alonso A, Lee DH, Delclos GL, Jenny NS, Jiang R, Lima JA, Symanski E, Jacobs DR Jr, Nettleton JA. Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis. J Nutr. 2011 Aug;141(8):1508-15. doi: 10.3945/jn.111.138115. Epub 2011 Jun 8.
Results Reference
background
PubMed Identifier
23592441
Citation
Flock MR, Rogers CJ, Prabhu KS, Kris-Etherton PM. Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab Res Rev. 2013 Sep;29(6):431-45. doi: 10.1002/dmrr.2414.
Results Reference
background
PubMed Identifier
17536128
Citation
Rankin JW, Turpyn AD. Low carbohydrate, high fat diet increases C-reactive protein during weight loss. J Am Coll Nutr. 2007 Apr;26(2):163-9. doi: 10.1080/07315724.2007.10719598.
Results Reference
background
PubMed Identifier
23079606
Citation
Fu Z, Shrubsole MJ, Smalley WE, Wu H, Chen Z, Shyr Y, Ness RM, Zheng W. Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol. 2012 Nov 1;176(9):766-76. doi: 10.1093/aje/kws157. Epub 2012 Oct 18.
Results Reference
background
PubMed Identifier
24428901
Citation
Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014 Jan 16;13:5. doi: 10.1186/1475-2891-13-5.
Results Reference
background
PubMed Identifier
22809634
Citation
Samadder NJ, Gornick M, Everett J, Greenson JK, Gruber SB. Inflammatory bowel disease and familial adenomatous polyposis. J Crohns Colitis. 2013 Apr;7(3):e103-7. doi: 10.1016/j.crohns.2012.06.021. Epub 2012 Jul 17.
Results Reference
background
PubMed Identifier
24282062
Citation
Henson CC, Burden S, Davidson SE, Lal S. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy. Cochrane Database Syst Rev. 2013 Nov 26;(11):CD009896. doi: 10.1002/14651858.CD009896.pub2.
Results Reference
background
PubMed Identifier
26146082
Citation
Chun E, Lavoie S, Michaud M, Gallini CA, Kim J, Soucy G, Odze R, Glickman JN, Garrett WS. CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. Cell Rep. 2015 Jul 14;12(2):244-57. doi: 10.1016/j.celrep.2015.06.024. Epub 2015 Jul 2.
Results Reference
background
PubMed Identifier
23955389
Citation
Dennis KL, Wang Y, Blatner NR, Wang S, Saadalla A, Trudeau E, Roers A, Weaver CT, Lee JJ, Gilbert JA, Chang EB, Khazaie K. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res. 2013 Oct 1;73(19):5905-13. doi: 10.1158/0008-5472.CAN-13-1511. Epub 2013 Aug 16.
Results Reference
background
PubMed Identifier
26982367
Citation
Mlecnik B, Bindea G, Angell HK, Maby P, Angelova M, Tougeron D, Church SE, Lafontaine L, Fischer M, Fredriksen T, Sasso M, Bilocq AM, Kirilovsky A, Obenauf AC, Hamieh M, Berger A, Bruneval P, Tuech JJ, Sabourin JC, Le Pessot F, Mauillon J, Rafii A, Laurent-Puig P, Speicher MR, Trajanoski Z, Michel P, Sesboue R, Frebourg T, Pages F, Valge-Archer V, Latouche JB, Galon J. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. Immunity. 2016 Mar 15;44(3):698-711. doi: 10.1016/j.immuni.2016.02.025.
Results Reference
background
PubMed Identifier
26377897
Citation
Biswas SK. Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity. 2015 Sep 15;43(3):435-49. doi: 10.1016/j.immuni.2015.09.001.
Results Reference
background
PubMed Identifier
27383982
Citation
Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016 Jul 7;535(7610):75-84. doi: 10.1038/nature18848.
Results Reference
background
PubMed Identifier
25198138
Citation
Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014 Oct;12(10):661-72. doi: 10.1038/nrmicro3344. Epub 2014 Sep 8.
Results Reference
background
PubMed Identifier
15743000
Citation
Laake KO, Line PD, Grzyb K, Aamodt G, Aabakken L, Roset A, Hvinden AB, Bakka A, Eide J, Bjorneklett A, Vatn MH. Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA). Scand J Gastroenterol. 2004 Dec;39(12):1228-35. doi: 10.1080/00365520410009320.
Results Reference
background
PubMed Identifier
15265001
Citation
Sharman MJ, Volek JS. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond). 2004 Oct;107(4):365-9. doi: 10.1042/CS20040111.
Results Reference
background
PubMed Identifier
9781303
Citation
Middleton E Jr. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol. 1998;439:175-82. doi: 10.1007/978-1-4615-5335-9_13.
Results Reference
background
PubMed Identifier
15607574
Citation
McCarty MF. Low-insulin-response diets may decrease plasma C-reactive protein by influencing adipocyte function. Med Hypotheses. 2005;64(2):385-7. doi: 10.1016/j.mehy.2004.03.039.
Results Reference
background
PubMed Identifier
10617974
Citation
De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 2000 Jan;71(1 Suppl):213S-23S. doi: 10.1093/ajcn/71.1.213S.
Results Reference
background
PubMed Identifier
16904534
Citation
Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006 Aug 15;48(4):677-85. doi: 10.1016/j.jacc.2006.03.052. Epub 2006 Jul 24.
Results Reference
background
PubMed Identifier
25837205
Citation
Salehi-Abargouei A, Saraf-Bank S, Bellissimo N, Azadbakht L. Effects of non-soy legume consumption on C-reactive protein: a systematic review and meta-analysis. Nutrition. 2015 May;31(5):631-9. doi: 10.1016/j.nut.2014.10.018. Epub 2014 Nov 7.
Results Reference
background
PubMed Identifier
26706026
Citation
Steckhan N, Hohmann CD, Kessler C, Dobos G, Michalsen A, Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis. Nutrition. 2016 Mar;32(3):338-48. doi: 10.1016/j.nut.2015.09.010. Epub 2015 Oct 28.
Results Reference
background
PubMed Identifier
23062863
Citation
Ahluwalia N, Andreeva VA, Kesse-Guyot E, Hercberg S. Dietary patterns, inflammation and the metabolic syndrome. Diabetes Metab. 2013 Apr;39(2):99-110. doi: 10.1016/j.diabet.2012.08.007. Epub 2012 Oct 11.
Results Reference
background
PubMed Identifier
11205485
Citation
Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):25-33.
Results Reference
background
PubMed Identifier
12947426
Citation
Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S, Berrino F. Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr. 2003 Sep;57(9):1079-88. doi: 10.1038/sj.ejcn.1601647.
Results Reference
background
PubMed Identifier
24283712
Citation
Marlow G, Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Jesuthasan AC, Han DY, Fraser AG, Ferguson LR. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Hum Genomics. 2013 Nov 27;7(1):24. doi: 10.1186/1479-7364-7-24.
Results Reference
background
PubMed Identifier
8532986
Citation
Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995 Sep 15;14(17):1933-40. doi: 10.1002/sim.4780141709.
Results Reference
background
PubMed Identifier
23961782
Citation
Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol. 2013 Aug 20;13:104. doi: 10.1186/1471-2288-13-104.
Results Reference
background
PubMed Identifier
20127029
Citation
Pizzamiglio S, Cossa G, Gatti L, Beretta GL, Corna E, Tinelli S, Verderio P, Perego P. Simultaneous confidence intervals to compare gene expression profiles using ABC transporter TaqMan microfluidic cards. Oncol Rep. 2010 Mar;23(3):853-60.
Results Reference
background
PubMed Identifier
22343615
Citation
Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res. 2012 Apr;10(4):504-15. doi: 10.1158/1541-7786.MCR-11-0342. Epub 2012 Feb 16.
Results Reference
background
PubMed Identifier
11846609
Citation
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8. doi: 10.1006/meth.2001.1262.
Results Reference
background
PubMed Identifier
34253565
Citation
Belfiore A, Ciniselli CM, Signoroni S, Gariboldi M, Mancini A, Rivoltini L, Morelli D, Masci E, Bruno E, Macciotta A, Ricci MT, Daveri E, Cattaneo L, Gargano G, Apolone G, Milione M, Verderio P, Pasanisi P, Vitellaro M. Preventive Anti-inflammatory Diet to Reduce Gastrointestinal Inflammation in Familial Adenomatous Polyposis Patients: A Prospective Pilot Study. Cancer Prev Res (Phila). 2021 Oct;14(10):963-972. doi: 10.1158/1940-6207.CAPR-21-0076. Epub 2021 Jul 12.
Results Reference
derived

Learn more about this trial

Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study

We'll reach out to this number within 24 hrs